DK0710248T3 - Melanom-inhiberende protein - Google Patents

Melanom-inhiberende protein

Info

Publication number
DK0710248T3
DK0710248T3 DK94925364T DK94925364T DK0710248T3 DK 0710248 T3 DK0710248 T3 DK 0710248T3 DK 94925364 T DK94925364 T DK 94925364T DK 94925364 T DK94925364 T DK 94925364T DK 0710248 T3 DK0710248 T3 DK 0710248T3
Authority
DK
Denmark
Prior art keywords
iib
iia
protein
htz
hybridise
Prior art date
Application number
DK94925364T
Other languages
Danish (da)
English (en)
Inventor
Brigitte Kaluza
Ulrich Bogdahn
Ttner Reinhard B
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of DK0710248T3 publication Critical patent/DK0710248T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK94925364T 1993-07-20 1994-07-19 Melanom-inhiberende protein DK0710248T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4324247 1993-07-20
PCT/EP1994/002369 WO1995003328A2 (de) 1993-07-20 1994-07-19 Melanom-inhibierendes protein

Publications (1)

Publication Number Publication Date
DK0710248T3 true DK0710248T3 (da) 2000-04-10

Family

ID=6493222

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94925364T DK0710248T3 (da) 1993-07-20 1994-07-19 Melanom-inhiberende protein

Country Status (14)

Country Link
US (1) US5770366A (zh)
EP (2) EP0710248B1 (zh)
JP (1) JP3435163B2 (zh)
CN (1) CN1056617C (zh)
AT (1) ATE185152T1 (zh)
AU (1) AU7531294A (zh)
CA (1) CA2167693C (zh)
DE (2) DE59408791D1 (zh)
DK (1) DK0710248T3 (zh)
ES (1) ES2139751T3 (zh)
GR (1) GR3032212T3 (zh)
IL (2) IL154248A (zh)
WO (1) WO1995003328A2 (zh)
ZA (1) ZA945278B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19653358A1 (de) * 1996-12-20 1998-06-25 Boehringer Mannheim Gmbh Immunoassay zum Nachweis von MIA
AU5923398A (en) 1997-01-21 1998-08-07 Human Genome Sciences, Inc. Polynucleotides and polypeptides encoding receptors
USRE39920E1 (en) 1997-05-30 2007-11-13 Xenomics, Inc. Methods for detection of nucleic acid sequences in urine
US6492144B1 (en) * 1997-05-30 2002-12-10 Diagen Corporation Methods for detection of nucleic acid sequences in urine
EP0945507A1 (de) * 1998-03-27 1999-09-29 Boehringer Mannheim Gmbh Tumorspezifische Expressionskontrollregion und deren Verwendung
US20020103360A1 (en) * 1998-09-01 2002-08-01 Yang Pan Novel protein related to melanoma-inhibiting protein and uses thereof
US20030072767A1 (en) * 1998-09-30 2003-04-17 Alexander Gaiger Compositions and methods for WT1 specific immunotherapy
EP1025871A1 (en) * 1999-01-28 2000-08-09 F. Hoffmann-La Roche Ag Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair
US6713293B1 (en) * 1999-02-08 2004-03-30 Friedrich Grummt Encapsulated cells containing an amplified expression vector as a drug delivery device
PL353065A1 (en) * 1999-06-30 2003-10-06 Takeda Chemical Industries, Ltd. Novel polypeptide and dna thereof
AU2001232967A1 (en) * 2000-01-25 2001-08-07 Hyseq, Inc. Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
EP1133994A1 (en) * 2000-03-11 2001-09-19 Biognostik Gesellschaft für biomolekulare Diagnostik mbH A method for reversing the immunosuppressive effects of the Melanoma Inhibitory Activity "MIA"
WO2001070253A1 (en) * 2000-03-23 2001-09-27 Akzo Nobel N.V. Use of mia in immunotherapy
US6613534B2 (en) 2001-03-20 2003-09-02 Wake Forest University Health Sciences MAP-2 as a determinant of metastatic potential
US20100212037A1 (en) * 2002-10-16 2010-08-19 Anja Katrin Bosserhoff Mia-2 protein
KR20090046893A (ko) * 2006-07-28 2009-05-11 노파르티스 아게 흑색종에서 치료학적 반응에 대한 조기 지표로서의 흑색종 억제 활성 (ｍｉａ) 단백질의 용도
CA2696403C (en) * 2007-08-22 2018-01-02 Xenomics, Inc. Methods of using mirna for detection of in vivo cell death
EP2563809B1 (en) 2010-04-27 2020-04-01 Scil Technology GmbH Stable aqueous mia/cd-rap formulations
CN103025875A (zh) * 2010-08-30 2013-04-03 霍夫曼-拉罗奇有限公司 原核表达构建体
ITRM20110134A1 (it) * 2011-03-22 2012-09-23 Matteo Bordignon Inibitori di mia (attività inibitoria melanoma) per identificare, prevenire e curare la vitiligine

Also Published As

Publication number Publication date
EP0710248A1 (de) 1996-05-08
AU7531294A (en) 1995-02-20
IL110385A (en) 2003-12-10
EP0947583A3 (de) 2000-05-03
IL110385A0 (en) 1994-10-21
CA2167693C (en) 2007-01-30
GR3032212T3 (en) 2000-04-27
CA2167693A1 (en) 1995-02-02
WO1995003328A2 (de) 1995-02-02
CN1056617C (zh) 2000-09-20
ATE185152T1 (de) 1999-10-15
IL154248A0 (en) 2003-09-17
JPH09500531A (ja) 1997-01-21
ES2139751T3 (es) 2000-02-16
EP0947583A2 (de) 1999-10-06
DE59408791D1 (de) 1999-11-04
US5770366A (en) 1998-06-23
DE4425481A1 (de) 1995-03-02
EP0710248B1 (de) 1999-09-29
JP3435163B2 (ja) 2003-08-11
IL154248A (en) 2008-08-07
ZA945278B (en) 1996-01-19
CN1133049A (zh) 1996-10-09
WO1995003328A3 (de) 1995-03-16

Similar Documents

Publication Publication Date Title
DK0710248T3 (da) Melanom-inhiberende protein
ID27693A (id) RANGKAIAN-RANGKAIAN NUKLEOTIDA YANG MENGKODE GEN pck
AU2795292A (en) Synthetic dna sequence having enhanced insecticidal activity in maize
HU9502466D0 (en) Novel pesticidal proteins and strains
AU2001271786A1 (en) Interferon-like protein zcyto21
HK1004150A1 (en) Calcium free subtilisin mutants.
GR3019043T3 (en) Protein having cytokin type activity, recombinant DNA coding for this protein, transformed cells and microorganisms.
CA2249233A1 (en) Mch4 and mch5, apoptotic protease, nucleic acids encoding and methods of use
CA2327266A1 (en) Pesticidal toxins and nucleotide sequences which encode these toxins
CA2102702A1 (en) Vitamin K-Dependent Carboxylase
AU2003214034A8 (en) Bacillus licheniformis mutant host cell
CA2252493A1 (en) .beta.-galactoside - .alpha. 2,6-sialyltransferase gene
CA2301902A1 (en) Novel extracellular serine protease
CA2155332A1 (en) Polypeptide having cold-stable pyruvate, orthophosphate dikinase activity, dna encoding the same and recombinant vector and transformed plants containing the dna
AU6659896A (en) Protein with plant protecting properties
AR005771A1 (es) Polipeptidos con actividad de mutanasa, secuencias de acidos nucleicos que los codifican, construccion de acidos nucleicos, vector de expresionrecombinante, celula huesped recombinante, metodos para producir los polipeptidos, polipeptido hibrido y uso de dichos polipeptidos para preparar
CA2144601A1 (en) Recombinant type ii collagenase from clostridium histolyticum and its use for isolating cells and groups of cells
AU5637298A (en) Novel cytochrome P450 gene
AU2003277889A1 (en) A gene encoding vitamin b6 phosphate phosphatase and use thereof
ATE398681T1 (de) Nukleotidsequenzen die für das mene-gen kodieren
MX9605473A (es) Polipeptido hk2 recombinante.
PT1117769E (pt) Clonagem e producao recombinante de enzimas de veneno de polistinae, tais como fosfolipase e hialuronidade e terapias imunologicas ai baseadas